Germline DDX41 Variants: Current Understanding and Future Directions

Current Hematologic Malignancy Reports · Published 2026-04-23 · DOI 10.1007/s11899-026-00779-0

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s11899-026-00779-0

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Prognostic and Predictive Models in Myelofibrosis · Current Hematologic Malignancy Reports · 2024 · Same journal
• Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms · Current Hematologic Malignancy Reports · 2026 · Same journal
• Splicing Factor Mutations in Chronic Myelomonocytic Leukemia: Biological Consequences and Therapeutic Implications · Current Hematologic Malignancy Reports · 2025 · Same journal
• From MRD To Match: the Role of Allogeneic Hematopoietic Cell Transplant in Philadelphia-Negative B-ALL · Current Hematologic Malignancy Reports · 2025 · Same journal
• How Do We Manage Chronic Lymphocytic Leukemia in India · Current Hematologic Malignancy Reports · 2024 · Same journal
• Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection · Current Hematologic Malignancy Reports · 2024 · Same journal
• Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia · Current Hematologic Malignancy Reports · 2024 · Same journal
• Maintenance Therapy Post-Stem Cell Transplantation for Patients with T-Cell Lymphomas · Current Hematologic Malignancy Reports · 2024 · Same journal
• Allogeneic Transplant for CMML · Current Hematologic Malignancy Reports · 2025 · Same journal
• Transplantation and Cellular Therapy for Older Adults—The MSK Approach · Current Hematologic Malignancy Reports · 2024 · Same journal